ArticleMolecular cancer therapeutics2012

Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy.

Atul Bedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.